1. Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
   Naoki Kadota et al, 2022, Cancer Reports CrossRef
2. Management of Large Cell Neuroendocrine Carcinoma
   Virginia Corbett et al, 2021, Frontiers in Oncology CrossRef
3. Based on SEER Database: Population Distribution, Survival Analysis, and Prognostic Factors of Organ Metastasis of Lung Large Cell Neuroendocrine Carcinoma
   Chang-fu Liu et al, 2022, Frontiers in Oncology CrossRef
4. Primary Mediastinal Neuroendocrine Tumor: A Case of Atypical Carcinoid
   Konstantinos Kosmas et al, 2021, Cureus CrossRef
5. Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
   Sara Manglaviti et al, 2022, Clinical Lung Cancer CrossRef
6. Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis
   Hao Chen et al, 2021, Cancers CrossRef
7. Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung
   Elizabeth Dudnik et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef
8. A case of acute myocarditis induced by PD-1 inhibitor (sintilimab) in the treatment of large cell neuroendocrine carcinoma
   Siming Zheng et al, 2023, Heliyon CrossRef
9. Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities
   Miriam Grazia Ferrara et al, 2021, Frontiers in Oncology CrossRef